Your search returned 91 results.

Sort
Results
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†. [electronic resource] by
Producer: 20150707 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.